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Background/aim: Boswellia from the family Burseraceae has been proposed for prevention of amnesia; however, the molecular
mechanism by which it affects memory is not clear. To reveal the potential molecular mechanism, the effects of boswellia on the
expression of two memory related genes, CREB and BDNF, were investigated.
Materials and methods: Twenty-one male rats were randomly divided into 3 groups (n = 7): the control group received distilled water
and the treatment groups received two doses of aqueous extract of Boswellia serrata gum resin (boswellia) (50 and 100 mg/kg) every day
for 4 weeks. The animals were tested by the Morris water maze (MWM) and their hippocampus was isolated. Expression of CREB and
BDNF genes was analyzed by Q-RT-PCR.
Results: The MWM test showed improvement in spatial learning and memory in both treatment groups. Gene expression analysis
revealed a significant increase in BDNF but not CREB expression in rats treated with both 50 and 100 mg/kg doses in comparison with
the control group.
Conclusion: Although boswellia exerts its effects on memory formation at least partly by affecting the expression of BDNF, the results
imply that boswellia probably affects memory via another BDNF-related pathway than the BDNF–CREB–BDNF cycle.
Key words: Boswellia, memory enhancing, BDNF, CREB, traditional medicine

1. Introduction
Medicinal plants are widely used for therapy of various
diseases throughout the world (1). Among plants with
medicinal value, the family Burseraceae is very important,
because its members have important pharmacological
properties (2). Gum resins of Boswellia (known as boswellia,
olibanum, or frankincense) from the family Burseraceae
are natives of Africa, India, and the Arabian Peninsula (3).
In traditional medicine, boswellia is recommended for
improving memory (4) and has been used for centuries for
the prevention of amnesia (5) as well as other pathologic
conditions such as inflammation (6). Evidence available
indicates that this gum resin could increase memory power
(5,7,8). Despite its historical and medical importance, gaps
still exist between our knowledge of the traditional uses of
boswellia and the scientific data available (9). In particular,
the molecular mechanism by which it affects memory is
not clear.
* Correspondence: khalaj@tabrizu.ac.ir

Memory is divided in two distinct forms based on
duration of data retention (10). Short-term memory (STM)
is independent of gene transcription and protein synthesis
whereas long-term memory (LTM) typically relies on
these procedures, since inhibition of protein synthesis
could lead to impairment of LTM formation (10). Protein
synthesis can be regulated by transcription factors capable
of tuning transcription rates such as cAMP-response
element binding protein (CREB) (11).
It was reported that CREB (12) and brain-derived
neuroterophic factor (BDNF) (13) are critical factors
involved in memory formation. CREB, a nuclear protein,
is implicated in many important neuronal processes such
as development, survival, and neuronal plasticity, which
are important for memory formation (12). Moreover,
CREB is critical for converting short-term memory to
long-term memory (14). It is a master transcription factor
that acts at a convergent point of three downstream target
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signal transduction pathways of BDNF. BDNF plays a
vital role not only in neuronal survival, but also in various
aspects of neural plasticity, such as neurogenesis, longterm potentiation (LTP), learning, and memory (15).
Effects of BDNF levels/expression on memory have been
investigated by several studies (13,15–17). For example,
upregulation of BDNF by incensole acetate, a fraction of
petroleum ether extract of boswellia, has been reported
(18). However, there is no report on considering the effects
of aqueous extract of boswellia on expression profiles of
genes involved in memory formation.
This study addresses the effects of aqueous extract of
Boswellia serrata gum resin on the expression of BDNF
and CREB genes with the aim of providing some insight
into the molecular mechanism by which boswellia affects
memory formation. To do this, male rats treated with
aqueous extract of boswellia were tested by Morris water
maze (MWM) to analyze spatial learning and memory.
Following the MWM test, the expression levels of CREB
and BDNF genes in the hippocampi of the rats were
studied by quantitative real-time RT-PCR.
2. Material and methods
2.1. Animals
Twenty-one male Wistar rats (8 weeks old and weighing 250
± 50 g) were obtained from Tehran University of Medical
Sciences and housed in groups of 7 per polycarbonate
cage. The animals were given standard laboratory chow
and water ad libitum. The animal care and protocols
met the NIH/USDA guidelines, under the approval of
the Institutional Animal Care and Use Committee (19).
Temperature in the animal room was maintained between
20 and 22 °C, and there was a 12-h light/dark cycle (light
from 0800 to 2000).
2.2. Preparing aqueous extract of boswellia and
treatments
The Boswellia serrata gum resin (boswellia) was purchased
from MOTHER HERBS PVT LTD (New Delhi, India).
Crushed granules or lumps of the gum exudates were
ground. One hundred grams of the powder was dissolved
in 1000 mL of distilled water and allowed to stand at room
temperature for 24 h. The supernatant was transferred to
50-mL Falcon tubes and centrifuged at 1000 rpm for 10
min. Subsequently, the supernatants were filtered using
Whatman No. 1 filter paper and stored at 4 °C.
The rats were randomly divided into three groups (n
= 7) and treated for 28 days. Group 1 (control) received
distilled water; group 2 received 50 mg/kg body weight
from boswellia aqueous extract orally with an oral
feeding needle, while group 3 received 100 mg/kg body
weight. The volumes were adjusted daily for each animal
according to weight, to reach the intended dosage, and
were administered once a day at a constant time.
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2.3. Morris water maze test
After 28 days of treatment, the animals were tested by
the MWM test to study spatial learning and memory.
The MWM is a circular, black-painted tank with 136-cm
diameter and 60-cm height containing water (20~24 °C).
This tank was divided into four quadrants (N, E, W, and S)
and filled with water to 40-cm depth. An invisible round
disk platform (made of Plexiglas) 10 cm in diameter was
used and located 1 cm beneath the surface of the water
(20). For spatial orientation different geometric shapes
were presented in the surroundings of the pool. The
training process was performed in six consecutive days
as four trials per day manner. Each trial was initiated by
placing the animals randomly in one of the four quadrants
of the pool. The rats must locate the immersed platform
as their only means of escape from the water. Each rat was
allowed 60 s to find the platform in each trial. If the rat was
unable to find the platform, it was gently guided and led
to the platform, where it remained for 10 s before being
removed from the pool. The intertrial interval time was
10 s in each block. Behavior in the maze was recorded by
a video-tracking computer system. More specifically, the
time to reach the hidden platform (escape latency), the
length of the swim path (distance traveled), and swimming
speed for each rat were recorded and used to assess the
performance of the animal in this memory test.
2.4. Gene expression analysis
After the MWM test, the rats were sacrificed and their
hippocampi were dissected following decapitation under
RNase-free conditions. Tissues were frozen in liquid
nitrogen immediately and were stored at –70 °C. Total
RNA was extracted with RNx-Plus RNA Isolation Reagent
according to the manufacturer’s instructions (Cinnagene
Inc., Iran), and quantified by Nanodrop ND1000. The
integrity of the extracted total RNA was checked by 1.2%
agarose gel electrophoresis. RNA was reverse transcribed,
using Thermo Scientific First Strand cDNA Synthesis kit
(Fermentas, Thermo Fisher Scientific, USA) with random
primers, according to the manufacturer’s instructions.
Then mRNA levels were analyzed by quantitative realtime RT-PCR (qRT-PCR). qRT-PCR was carried out
by iQ5 Real-Time PCR detection system (Bio-Rad
Laboratories, Inc., Hercules, CA, USA) apparatus using
Syber green I. Primers were as follows: CREB (Forward:
5’-CACATAGCCCAGGTATCC-3’
and
Reverse:
5’-TGAACTGTTTGGACTTGTGG-3’); BDNF (Forward:
5’-GTGACAGTATTAGCGAGTGGG- 3’ and Reverse:
5’-ATTGCGAGTTCCAGTGCC-3’) GAPDH (Forward:
5’-AACGACCCCTTCATTGACC-3’
and
Reverse:
5’-TCCACGACATACTCAGCACC-3’). The GAPDH
expression level was used as an endogenous normalization
factor. The primers were designed using Gene Runner
software and synthesized by Bioneer Inc. (Korea). All PCR
reactions were run in duplicate.
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2.5. Data analysis
The relative expression levels of CREB and BDNF genes in
the hippocampus of rats treated with boswellia to that of
control animals were calculated by 2-ΔCT method. ΔCT was
considered as the difference in threshold cycle (CT) values
corresponding to target gene and GAPDH (CT of target
gene – CT of GAPDH). qRT-PCR data were analyzed
using GraphPad Prism version 5.02. One-way ANOVA
followed by Tukey’s multiple comparison test with SPSS 10
analytic software (SPSS Inc., Chicago, MI, USA) was used
to evaluate differences in behavioral scores in the MWM
test. The unpaired Student’s t-test was used to analyze the
difference between two groups of animals. A P value of
0.05 was set as the level of significance.
3. Results
3.1. Effect of boswellia on the spatial memory parameters
in the MWM test
To examine whether boswellia aqueous extract affected the
memory power of animals, the spatial memory parameters
were investigated by MWM test. The swimming speed
was not changed during the trials in any of the periods of
boswellia aqueous extract administration, indicating no
motor disturbances occurred in the animals. Therefore,
the escape latency and distance traveled parameters could
be compared within groups.
3.2. Boswellia aqueous extract significantly decreased
escape latency in rats
All groups of rats including control and treated animals
learned to find the hidden platform in the MWM test. A
significant difference (P < 0.001) between the first and
sixth days of training was observed in escape latency
of all three groups (Table). This means that training of
animals appropriately occurred and all animals are normal
regarding mental health. Comparing the escape latencies
of the three groups on the sixth day revealed that both
groups treated with 50 mg/kg and 100 mg/kg of boswellia
extract had lower scores than the control group (Figure
1). This difference was statistically significant (P < 0.05),

Figure 1. Comparison of effects of the boswellia aqueous extract
on the escape latencies of three rat groups on day 6 of the MWM
test. Both 50 and 100 mg/kg boswellia extracts led to significant
reductions in escape latencies on day 6 in comparison to the control group (*P < 0.05). There was no significant difference between the two treated groups.

which shows the positive effects of boswellia aqueous
extract on memory enhancement. Comparison of the
escape latencies of groups treated with 50 mg/kg and 100
mg/kg revealed no significant differences.
3.3. Boswellia aqueous extract significantly decrease
distance traveled of rats
The time of swimming to reach the platform was compared
in all three groups. The comparison revealed significant
differences (P < 0.001) in distance traveled between the
first and sixth days of training among all three groups
(Table), which implies learning appropriately occurred in
all three groups. Comparison of distance traveled scores
of the sixth day of the three groups revealed that both
groups treated with boswellia (50 and 100 mg/kg) had
lower scores than the control group and the difference was
statistically significant (P < 0.05) (Figure 2). There was no

Table. Effects of boswellia aqueous extract on spatial memory parameters in the Morris water maze test.
Groups

Escape latency (s)

Distance traveled (cm)

Day 1

Day 6

Day 1

Day 6

Control

33.37 ± 1.7

12.63 ± 2.1**

402.3 ± 23.8

154.8 ± 26.6***

Bos 50 mg/kg

30.94 ± 2.9

6.49 ± 6.0**

451.8 ± 42.4

76.4 ± 13.9***

Bos 100 mg/kg

30.87 ± 1.7

7.68 ± 6.3**

383.5 ± 19.6

88.5 ± 13.3***

Values are mean ± SEM for 7 animals per group. A significant difference between day 1 and day 6 of
training was observed in escape latency (** P < 0.001) and distance traveled (*** P < 0.001) of all three
groups.
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Figure 2. Comparison of effects of the boswellia aqueous extract
on the distance traveled scores of three rat groups on day 6 of the
MWM test. Both 50 and 100 mg/kg boswellia extracts led to significant reductions in distance traveled scores on day 6 in comparison to the control group (*P < 0.05). There was no significant
difference between the two treated groups.

significant difference between the distances traveled scores
of the two treated groups.
3.4. Boswellia aqueous extract did not alter hippocampal
expression of CREB transcripts
To understand the potential molecular mechanism by
which the boswellia affects learning and memory we
analyzed expression levels of CREB transcripts in the
hippocampus of rats treated with boswellia aqueous
extracts in comparison to the control group. Following
MWM tests, the animals were anesthetized and their
hippocampus was isolated. Total RNA was extracted and
reverse transcribed to cDNA. The expression levels of
CREB transcripts were quantified by quantitative realtime PCR normalizing to GAPDH. Analysis of the results
showed no significant differences in expression levels of
CREB in the treated groups in comparison to the control
group (Figure 3).
3.5. Boswellia aqueous extract increases the hippocampal
expression of BDNF transcripts
To evaluate the effects of Boswellia aqueous extract
on BDNF expression, the transcripts of BDNF in the
hippocampus of the rats were analyzed by quantitative
real-time PCR. The results obtained showed that the
boswellia aqueous extract upregulates expression of BDNF
transcripts. Rats treated with both doses of boswellia (50
mg/kg and 100 mg/kg body weight) exhibited significantly
higher (P < 0.05) BDNF expression levels in comparison
to the control group (Figure 4). Moreover, the BDNF
expression in the rats treated with the dose of 100 mg/
kg was significantly higher than that of the 50 mg/kg (P
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Figure 3. The expression levels of CREB transcripts were quantified by quantitative real-time PCR in the hippocampus of rats
treated with 50 and 100 mg of boswellia aqueous extract per kg
of body weight as well as the control. The expression levels were
normalized to expression level of GAPDH internal control. The
results are mean values of 7 samples per group and error bars
indicate the SD.

Figure 4. The expression levels of BDNF transcripts were quantified by quantitative real-time PCR in the hippocampus of rats
treated with 50 and 100 mg of boswellia aqueous extract per kg
of body weight as well as the control. The expression levels were
normalized to expression level of GAPDH internal control. The
results are mean values of 7 samples per group and error bars indicate the SD. Data points marked with an asterisk are significant
at P < 0.05.
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< 0.05), which implies dose-dependent upregulation of
BDNF with boswellia.
4. Discussion
In the present study, the effect of boswellia aqueous
extract on spatial memory retention was investigated in
adult Wistar rats by MWM test followed by quantitative
analysis of CREB and BDNF expression levels in their
hippocampi tissues. The results demonstrated that
administration of the boswellia aqueous extract led to
significant reductions in escape latency and distance
traveled values of rats compared to the distilled watertreated control group, which implies the boswellia aqueous
extract may positively affect spatial memory. This finding
is in line with reports by others on the effect of boswellia
resin for memory enhancement (5,7,8,21,22) as well as a
study on prevention of memory impairments caused by
methimazole-induced hypothyroidism in male rats (23).
It was reported that treatment of rats with boswellia might
induce morphological changes in hippocampus subregions
of the rat brain. These changes include increases in the
volume of the cellular layer and individual neurons of
dentate gyrus and cornu ammon 3 (CA3) regions (21),
neurite outgrowth, branching, and tubulin polymerization
dynamics (5) as well as number of neurons and neuronal
dendritic spines (7). These morphological changes are
governed by several gene transcription and protein
synthesis procedures, which are mediated by transcription
factors. A master transcription factor that plays a critical
role in memory formation is CREB (11,12). This protein
acts in a signaling pathway in which BDNF functions
both upstream and downstream of it. To understand
the molecular mechanism by which boswellia aqueous
extract affects memory, we analyzed expression of CREB
and BDNF genes using quantitative real-time PCR. The
results showed no significant change in the expression of
CREB transcripts in the hippocampus of the rats treated
with boswellia in comparison to the controls. However, a
significant increase in the expression of BDNF transcripts
was observed.
It was reported that BDNF plays a crucial role in
cognition, learning, and memory formation by modulating
synaptic plasticity (24). It exists in pre- and postsynaptic
compartments and can undergo both retrograde and

anterograde transport. When BDNF releases into the
synaptic cleft, it may interact with and activate both preand postsynaptically tropomyosin related kinase (TrkB)
receptors (25). TrkB activation triggers activation of three
intracellular pathways: extracellular signal-regulated
kinase (ERK), phosphotidylinositol-3 kinase (PI-3K),
and phospholipase C-ɣ (PLC-ɣ) cascades (25,26), which,
in turn, may activate transcription factors such as CREB.
Finally, CREB activates transcription of other genes
involved in memory formation and synaptic plasticity
including BDNF (27). Therefore, release of intracellular
BDNF reservoir from neuronal spines can control
production of BDNF itself (BDNF–CREB–BDNF cycle).
According to the results of the present study, BDNF was
upregulated while CREB was not affected by the aqueous
extract of boswellia. This means that it may affect memory
via another pathway than the BDNF–CREB–BDNF cycle.
One potential pathway might be the mammalian target of
rapamycin (mTOR) signaling, since it was also reported
that BDNF affects the memory process by activating
the mTOR pathway, which is independent of CREB
transcription factor. BDNF activates the mTOR kinase to
regulate GluR1 expression, a glutamate receptor subunit
that is required for memory formation (28). Increased
expression levels of GluR1 results in increased proportion
of GluR1-containing AMPA receptors. These receptors are
trafficked to the synapse in an activity-dependent manner,
which may promote LTP. This pathway is inactive under
basal conditions, but it can be triggered upon stimulation
(29).
In conclusion, our results showed some enhancements
in the spatial memory of the rats treated with aqueous
extract of boswellia. This improvement might be at least
partly due to BDNF, which is upregulated by aqueous
extract of boswellia. However, the expression of CREB was
not affected. These results imply that boswellia probably
affects memory via another BDNF-related pathway than
the BDNF–CREB–BDNF cycle.
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